120 related articles for article (PubMed ID: 2653715)
1. Synergistic interaction of cefotaxime and its metabolite desacetylcefotaxime demonstrated by drug-impregnated disks.
Stevens DL; Bergstrom R; Gibbons A
Diagn Microbiol Infect Dis; 1989; 12(1):73-80. PubMed ID: 2653715
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial activity of cefotaxime, desacetylcefotaxime, and the combination of the two.
Friis H
Diagn Microbiol Infect Dis; 1989; 12(1):67-72. PubMed ID: 2714074
[TBL] [Abstract][Full Text] [Related]
3. Activity of cefotaxime/desacetylcefotaxime with two aminoglycosides against gram-negative pathogens: an example of interactive synergy.
Jenkins SG
Diagn Microbiol Infect Dis; 1989; 12(1):51-5. PubMed ID: 2714073
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the in vitro action and interaction of cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides spp.
Aldridge KE
Diagn Microbiol Infect Dis; 1989; 12(1):45-50. PubMed ID: 2714072
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cefotaxime alone and in combination with desacetylcefotaxime against strains of Staphylococcus aureus that produce variants of staphylococcal beta-lactamase.
Stratton CW; Kernodle DS; Eades SC; Weeks LS
Diagn Microbiol Infect Dis; 1989; 12(1):57-65. PubMed ID: 2785444
[TBL] [Abstract][Full Text] [Related]
6. [In vitro synergy between cefotaxime and its main metabolite, desacetylcefotaxime].
Kobayashi S; Arai S; Hayashi S; Sakaguchi T; Kawana R
Jpn J Antibiot; 1988 May; 41(5):594-601. PubMed ID: 3216482
[TBL] [Abstract][Full Text] [Related]
7. Population analysis of susceptibility to cefotaxime and desacetyl-cefotaxime in Staphylococcus and Enterobacteriaceae.
Hansen BG; Søgaard P
Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):243-7. PubMed ID: 3875967
[TBL] [Abstract][Full Text] [Related]
8. Synergistic antibacterial interaction of cefotaxime and desacetylcefotaxime.
Molinari G; Saverino D; Paglia P; Debbia EA; Schito GC
J Chemother; 1991 Feb; 3(1):6-12. PubMed ID: 2019866
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of disk susceptibility testing of cefotaxime/desacetylcefotaxime.
Fuchs PC; Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1989; 12(1):81-5. PubMed ID: 2714075
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of desacetylcefotaxime and the interaction with its parent compound, cefotaxime.
Oizumi K; Hayashi I; Aonuma S; Konno K
Drugs; 1988; 35 Suppl 2():57-61. PubMed ID: 3135170
[TBL] [Abstract][Full Text] [Related]
11. Interaction of cefotaxime and desacetylcefotaxime against pathogenic bacteria. Assessment with the serum bactericidal test.
Reller LB
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):55S-61S. PubMed ID: 6086219
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of cefotaxime alone and in combination with desacetylcefotaxime against Bacteroides fragilis.
Wasilauskas BL
Diagn Microbiol Infect Dis; 1989; 12(1):39-43. PubMed ID: 2714071
[TBL] [Abstract][Full Text] [Related]
13. A reassessment of the activity of the third-generation cephalosporins against anaerobes and Staphylococcus aureus.
Canawati HN
Am J Surg; 1992 Oct; 164(4A Suppl):24S-27S. PubMed ID: 1443357
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the bactericidal activity of cefotaxime and desacetylcefotaxime alone and in combination against Bacteroides fragilis group organisms.
Aldridge KE; Weeks LS; Stratton CW; Sanders CV
Diagn Microbiol Infect Dis; 1989; 12(2):165-70. PubMed ID: 2752714
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of cefoxitin, cefotaxime alone, and in combination with desacetylcefotaxime against the Bacteroides species.
Canawati HN
Diagn Microbiol Infect Dis; 1989; 12(1):33-7. PubMed ID: 2714070
[TBL] [Abstract][Full Text] [Related]
16. In vitro comparison of the activity of cefotaxime and desacetylated cefotaxime and of their combination.
Nanetti A; La Placa M
J Chemother; 1990 Jun; 2(3):159-63. PubMed ID: 2380765
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in vitro activity of cefotaxime and desacetylcefotaxime alone and in combination against 320 gram-negative clinical isolates.
Piédrola G; Galan I; Leyva A; Maroto MC
Drugs; 1988; 35 Suppl 2():62-4. PubMed ID: 3135171
[TBL] [Abstract][Full Text] [Related]
18. Synergistic activity of cefotaxime and desacetylcefotaxime against the Bacteroides fragilis group.
Cornick NA; Gorbach SL
Diagn Microbiol Infect Dis; 1988 Jun; 10(2):81-4. PubMed ID: 3224498
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
Schmalreck AF; Wildfeuer A
Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacokinetics of cefotaxime and ceftizoxime and the role of desacetylcefotaxime in the antibacterial activity of cefotaxime.
Quintiliani R; Nightingale CH; Tilton R
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):63S-70S. PubMed ID: 6086220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
